RSLV-133

N/A

Report date: 2023/09/25 10:50:45

Base Information

Drug NameRSLV-133
Drug Alias NameRSLV-133
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionInterferon alpha inhibitors
TargetsInterferon alpha
Therapy Area/IndicationsLupus Nephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWashington University
China Registration ClassN/A

Develop Information

Active CompaniesResolve Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsLupus Nephritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A